Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

The Charles County Animal Care Center is highlighting an especially charming adoptable dog named Lilly. The 1-year-old Lab mix weighs 26 pounds and is described as 26 pounds of pure wiggle-powered ...

The world’s most valuable pharmaceutical company, Eli Lilly & Co., on Tuesday officially opened its new Lilly Seaport Innovation Center in Boston. The $700 million building will accommodate Lilly’s ...

Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

Chai Discovery, the AI company engineering models to discover new molecules, today announced that certain Chai Discovery ...

During the JPM Healthcare Conference, pharma giant Eli Lilly and Co. and NVIDIA announced a partnership to develop a San Francisco-based AI co-innovation lab, including an investment of up to $1 ...

By incorporating nonclinical testing services, the partnership seeks to standardise testing protocols across organisations.

INDIANAPOLIS — One Hoosier university will soon have a new biosciences facility, thanks to a $138 million grant from the Lilly Endowment. The money will be used to help Indiana University build the IU ...

A biotech firm founded by Harvard Medical School chemist and molecular biologist Timothy Springer will become part of Eli Lilly and Company’s R&D pipeline following a $3.2 billion acquisition. Lilly ...

“It’s been a rollercoaster ride,” said Nicole Asher, owner/founder of Buddha Dog Rescue & Recovery based in New Jersey. Lilly was hiding in thick reeds along the New York State Thruway. At one point, ...

Lila Biologics, a startup that spun out of Nobel Laureate David Baker’s lab at the University of Washington, announced a collaboration with pharmaceutical giant Eli Lilly to develop therapies for ...